WAYNE, Pa., Feb. 18, 2014 /PRNewswire/ -- Ryan &
Maniskas, LLP is investigating potential claims against the board
of directors of LCA-Vision Inc. ("LCA-Vision" or the "Company")
(NASDAQ: LCAV) concerning possible breaches of fiduciary duty and
other violations of law related to the Company's efforts to sell
the Company to PhotoMedex, Inc. in a transaction valued at
approximately $106.4 million.
(Logo: http://photos.prnewswire.com/prnh/20121112/MM11729LOGO
)
If you own shares of LCA-Vision and would like to learn more
about this class action or if you wish to discuss these matters and
have any questions concerning this announcement or your rights,
contact Richard A. Maniskas, Esquire
toll-free at (877) 316-3218 or to sign up online, visit:
www.rmclasslaw.com/cases/lcav. You may also email Mr.
Maniskas at rmaniskas@rmclasslaw.com.
Under the terms of the agreement, public shareholders of
LCA-Vision will receive $5.37 per
share in cash for each share of LCA-Vision they own.
Our investigation concerns possible breaches of fiduciary duty
and other violations of state law by LCA-Vision's Board of
Directors for not acting in the Company's shareholders' best
interests in connection with the sale process.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide. To learn more
about the class action process, please visit:
www.rmclasslaw.com.
CONTACT: Ryan & Maniskas,
LLP
Richard
A. Maniskas,
Esquire
995
Old Eagle School Rd., Suite
311
Wayne,
PA
19087
877-316-3218
www.rmclasslaw.com/cases/lcav
rmaniskas@rmclasslaw.com
SOURCE Ryan & Maniskas, LLP